Enhanced Fluid Control Devices for Reduced Contamination in Bodily Fluid Sampling

An innovative fluid control device with dynamically adjustable flow paths, integrated sensors, and modular designs to minimize contaminants in bodily fluid samples, enhancing the efficiency and safety of sampling procedures.

The original patent, 'Fluid control devices and methods of using the same', addresses the issue of contaminants in bodily fluid samples. However, the existing design has limitations in terms of fluid flow rates, turbulence-induced contamination, and adaptability to different sample types. The new inventive concept overcomes these limitations by introducing dynamically adjustable flow paths, integrated sensors, and modular designs to reduce contaminants and improve sampling efficiency.

The enhanced fluid control device features a sequestration chamber with a dynamically adjustable flow path, allowing for optimized fluid flow rates and minimized turbulence-induced contamination. The device also incorporates an integrated sensor to detect and quantify contaminants in the initial volume of bodily fluid, enabling the controller to adjust the flow path accordingly. Additionally, the device features a modular, interchangeable sequestration chamber to accommodate different types of bodily fluid samples and contaminants. The device can be used in various methods, including diverting an initial volume of bodily fluid into the sequestration chamber and then using a secondary flow path to channel a subsequent volume of bodily fluid, substantially free from contaminants, to a collection device.

The new claims introduce novel features such as dynamically adjustable flow paths, integrated sensors, and modular designs, which are not present in the original patent. These features provide a significant improvement in reducing contaminants and improving sampling efficiency, making the new inventive concept non-obvious and innovative compared to the original patent.

Alternative embodiments of the inventive concept could include using different materials or coatings for the sequestration chamber, such as hydrophobic coatings to minimize microbial adhesion and biofilm formation. Variations of the device could also include different sensor types or arrangements, or different modular designs to accommodate specific sample types or contaminants.

The enhanced fluid control device has significant commercial potential in the healthcare industry, particularly in the fields of diagnostic testing, blood sampling, and medical research. The device's ability to reduce contaminants and improve sampling efficiency could lead to increased adoption and revenue growth in these markets.